These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14697879

  • 1. Computer modelling and visualization of active site of monoamine oxidases.
    Veselovsky AV, Ivanov AS, Medvedev AE.
    Neurotoxicology; 2004 Jan; 25(1-2):37-46. PubMed ID: 14697879
    [Abstract] [Full Text] [Related]

  • 2. [Modeling of monoamine oxidase B active site by computer moulding].
    Veselovskiĭ AV, Tikhonova OV, Ivanov AS, Medvedev AE.
    Vopr Med Khim; 2001 Jan; 47(6):642-51. PubMed ID: 11925756
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibitors and computer modelling of the active site of monoamine oxidase.
    Medvedev AE, Ivanov AS, Veselovsky AV.
    Neurobiology (Bp); 2000 Jan; 8(2):201-14. PubMed ID: 11061215
    [Abstract] [Full Text] [Related]

  • 4. Modeling of substrate-binding region of the active site of monoamine oxidase A.
    Veselovsky AV, Medvedev AE, Tikhonova OV, Skvortsov VS, Ivanov AS.
    Biochemistry (Mosc); 2000 Aug; 65(8):910-6. PubMed ID: 11002183
    [Abstract] [Full Text] [Related]

  • 5. An approach for visualization of the active site of enzymes with unknown three-dimensional structures.
    Veselovsky AV, Tikhonova OV, Skvortsov VS, Medvedev AE, Ivanov AS.
    SAR QSAR Environ Res; 2001 Aug; 12(4):345-58. PubMed ID: 11769118
    [Abstract] [Full Text] [Related]

  • 6. [Use of selective inhibitors for computer modeling of the monoamine oxidase active site].
    Veselovskiĭ AV, Ivanov AS, Medvedev AE.
    Vopr Med Khim; 1997 Aug; 43(6):527-36. PubMed ID: 9503570
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N, Simşek OO, Ercan A, Yelekçi K, Sahin ZS, Işik S, Uçar G, Bilgin AA.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6761-72. PubMed ID: 19682910
    [Abstract] [Full Text] [Related]

  • 8. The FAD binding sites of human monoamine oxidases A and B.
    Edmondson DE, Binda C, Mattevi A.
    Neurotoxicology; 2004 Jan 15; 25(1-2):63-72. PubMed ID: 14697881
    [Abstract] [Full Text] [Related]

  • 9. Molecular docking of inhibitors into monoamine oxidase B.
    Harkcom WT, Bevan DR.
    Biochem Biophys Res Commun; 2007 Aug 24; 360(2):401-6. PubMed ID: 17597580
    [Abstract] [Full Text] [Related]

  • 10. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A, Yabanoglu S, Sinha BN, Ucar G, Basu A, Jayaprakash V.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):132-6. PubMed ID: 19945874
    [Abstract] [Full Text] [Related]

  • 11. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A, Fierro A, McLean TH, Castillo M, Cassels BK, Reyes-Parada M, Nichols DE.
    J Med Chem; 2005 Apr 07; 48(7):2407-19. PubMed ID: 15801832
    [Abstract] [Full Text] [Related]

  • 12. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M, Mahapatra M, Yabanoglu S, Ucar G, Sinha BN, Basu A, Mishra N, Sharon A, Kulandaivelu U, Jayaprakash V.
    Bioorg Med Chem; 2010 Mar 01; 18(5):1875-81. PubMed ID: 20149663
    [Abstract] [Full Text] [Related]

  • 13. [Computer modelling of monoaminoxidases].
    Veselovsky AV, Ivanov AS, Medvedev AE.
    Biomed Khim; 2015 Mar 01; 61(2):265-71. PubMed ID: 25978392
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B.
    La Regina G, Silvestri R, Gatti V, Lavecchia A, Novellino E, Befani O, Turini P, Agostinelli E.
    Bioorg Med Chem; 2008 Nov 15; 16(22):9729-40. PubMed ID: 18951803
    [Abstract] [Full Text] [Related]

  • 15. Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivators.
    Palmer SL, Mabic S, Castagnoli N.
    J Med Chem; 1997 Jun 20; 40(13):1982-9. PubMed ID: 9207939
    [Abstract] [Full Text] [Related]

  • 16. Modeling of human monoamine oxidase A: from low resolution threading models to accurate comparative models based on crystal structures.
    Léonard N, Lambert C, Depiereux E, Wouters J.
    Neurotoxicology; 2004 Jan 20; 25(1-2):47-61. PubMed ID: 14697880
    [Abstract] [Full Text] [Related]

  • 17. [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].
    Ramsay RR.
    Vopr Med Khim; 1997 Jan 20; 43(6):457-70. PubMed ID: 9503563
    [Abstract] [Full Text] [Related]

  • 18. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G, Silvestri R, Artico M, Lavecchia A, Novellino E, Befani O, Turini P, Agostinelli E.
    J Med Chem; 2007 Mar 08; 50(5):922-31. PubMed ID: 17256833
    [Abstract] [Full Text] [Related]

  • 19. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
    Binda C, Wang J, Li M, Hubalek F, Mattevi A, Edmondson DE.
    Biochemistry; 2008 May 20; 47(20):5616-25. PubMed ID: 18426226
    [Abstract] [Full Text] [Related]

  • 20. Is one amino acid responsible for substrate specificity of monoamine oxidase A and B?
    Veselovsky AV, Ivanov AS, Medvedev AE.
    Biochemistry (Mosc); 1998 Dec 20; 63(12):1441-6. PubMed ID: 9916164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.